GB2126081A - Fluoride-containing compositions containing permselective polymers - Google Patents
Fluoride-containing compositions containing permselective polymers Download PDFInfo
- Publication number
- GB2126081A GB2126081A GB08321144A GB8321144A GB2126081A GB 2126081 A GB2126081 A GB 2126081A GB 08321144 A GB08321144 A GB 08321144A GB 8321144 A GB8321144 A GB 8321144A GB 2126081 A GB2126081 A GB 2126081A
- Authority
- GB
- United Kingdom
- Prior art keywords
- fluoride
- composition according
- polymer
- phosphate
- permselective
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/19—Cosmetics or similar toiletry preparations characterised by the composition containing inorganic ingredients
- A61K8/20—Halogens; Compounds thereof
- A61K8/21—Fluorides; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/72—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
- A61K8/84—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds obtained by reactions otherwise than those involving only carbon-carbon unsaturated bonds
- A61K8/85—Polyesters
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q11/00—Preparations for care of the teeth, of the oral cavity or of dentures; Dentifrices, e.g. toothpastes; Mouth rinses
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Birds (AREA)
- Epidemiology (AREA)
- Chemical & Material Sciences (AREA)
- Inorganic Chemistry (AREA)
- Oral & Maxillofacial Surgery (AREA)
- Cosmetics (AREA)
Abstract
A composition comprising fluoride ion and a polymer which is permselective to fluoride ion is provided for dental prophylaxis or therapy. The composition may be formulated as a gel, for example in a toothpaste; as a dentifrice; or as a mouthwash. The polymer comprises hydrophobic groups and backbone phosphatic groups, and is especially a poly(cyclohexylene phosphate).
Description
SPECIFICATION
Fluoride-containing compositions
The invention relates to fluoride-containing compositions; more particularly, this invention relates to fluoride-containing compositions for use in dental prophylaxis and therapy.
Compositions comprising fluoride ions occupy an important place in preventative dentistry: fluoride ions have both a systemic and topical benefit to teeth. The latter can be obtained either by the addition of a fluoride, such as sodium fluoride, to the central water supply or from the deliberate topical application of solutions, gels or pastes. Gels are preferred to solutions since they can more easily be kept in contact with the teeth for the required time.
The prophylatic and therapeutic use of acidulated phosphate fluoride (APF) gels to strengthen and restore dental enamel against acid attack has been common for two decades (Wellock and Brudevold: Arch. Oral Biol. 8, pages 1 79-182, 1963). APF gels typically comprise a cellulose derivative, sodium fluoride, hydrofluoric acid and sodium phosphate and have a fluoride concentration of about 20,000 ppm.
However, one teaspoonful of such a gel is acutely toxic to a 20 kg child and three-quarters of a cup of such a gel constitutes a lethal dose of fluoride. In consequence, treatment has to be effected by the dental practitioner to avoid accidental fluorosis.
This invention, in one aspect, seeks to provide fluoride prophylaxis or therapy in dentistry utilising fluoride concentrations which will obviate, or make much less possible, accidental fluorosis. In another aspect, this invention seeks to provide more effective fluoride propylaxis or therapy utilising conventional fluoride concentrations.
According to the present invention, there is provided a polymer which is permselective with respect to fluoride ion and which comprises both hydrophobic groups and backbone phosphate groups for use in dental prophylaxis or therapy.
Particularly important dental prophylaxis or therapy includes use in reduction of dental caries and use in enhancing the resistance of dental enamel to acid attack.
One important class of polymer which has proved valuable in the performance of the invention comprises the saturated or unsaturated, substituted or unsubstituted poly(organo phosphate)s. Preferably, the polymer comprises a substituted or unsubstituted poly(cycloalkyene phosphate), especially a substituted or unsubstituted poly(cyclohexylene phosphate). The preferred polymer has the formula:
wherein n represents a number greater than two, typically from 10 to 100, preferably from 25 to 60. The formula acknowledges that a mixture of isomers, including stereoisomers, may be present.
Poly( 1 ,2-cyclohexylene phosphate) is the particularly preferred polymer. The number average molecular weight of the polymer may be from 2,000 to 20,000 or more, preferably from 5,000 to 10,000.
These polymers are known per se; they may be prepared by analogy with the process disclosed in
French Patent No. 1 172892 or by the process disclosed in US Patent No. 3520849. For completeness, however, Example 1 describes a preparation.
Desirably, the polymers used in this invention are cross-linked with a minor amount (typically no more than 10 wt%, preferably less than 5 wt%) of a cross-linking monomer. This may be a polyhydroxy compound of functionality greater than 2; for example, glycerol or pentaerythritol or a tris-(or higher) phosphate compound; for example, phytic acid, or a precursor thereof such as an acid chloride or anhydride. Free radical cross-linking may be utilised, for example by copolymerising a minor amount of an ethylenically unsaturated moiety; and then polymerising these moieties in a manner known per se. Examples of such moieties include allyloxypropyldiol and hydroxyethyl methacrylate (HEMA).
Polymers usefui in the performance of this invention should be layer forming polymers; should be capable of binding fluoride ion; should have calcium salts which are insoluble in slightly alkaline media, such as oral fluids; they should not etch dental enamel in the presence of fluoride ion; they, and any decomposition products, should be non-toxic at the concentrations administered. This is the case with the above-mentioned polymers.
In accordance with a further aspect of this invention, there is provided a composition comprising:
(i) a polymer which is permselective with respect to fluoride ion and which comprises both hydrophobic groups and backbone phosphate groups; and
(ii) a source of fluoride ion.
By "backbone phosphate group" is meant herein a phosphate group which is linked by a plurality of covalent bonds to the polymer network (in contra distinction to a pendant phosphate group which is linked by a single covalent bond to the polymer network).
By "permselective with respect to fluoride ion" is meant herein that a layer of the subject polymer acts as a semi-permeable membrane with respect to fluoride ion.
By "source of fluoride ion" is meant herein any species which can, in the presence of aqueous media and a permselective polymer as aforesaid, present fluoride ion to dental enamel. Examples include a fluoride complex such as one comprising the Al F8-3 anion; a fluoride of a transition metal of Groups IVA or VIII such as ZrF4,
FeF3; a fluoride of a metal of Group IVB, namely
SnF2 and PbF2; and a bifluoride such as KHF2. A preferred source of fluoride ion comprises an alkali metal fluoride, such as sodium fluoride.
Compositions of the invention may comprise fluoride concentrations typically greater than 5,000 ppm; for example up to 10,000 ppm or even up to 25,000 ppm. Such compositions would have to be administered by the dental practitioner but would provide more effective fluoride prophylaxis or therapy than conventional
APF compositions. More preferably, however, compositions of the invention comprise fluoride concentrations of 5,000 ppm or less; for example less than 2,500 ppm, preferably less than 1,000 ppm. Compositions comprising as little as 500 to 800 ppm fluoride have been found to give useful effects.
The compositions of this invention may be dissolved in aqueous media, for example to provide a mouthwash which may also comprise a disinfectant. Preferably, however, they are formulated as a gel which may be incorporated in a dentifrice or a toothpaste. The gel may comprise a conventional thickening agent such as an alginate, carboxymethyl cellulose or poly(N-vinyl pyrrolidone).
The following Examples illustrate the invention:
Example 1
This Example describes the preparation of poly(cyclohexyl phosphate).
11.61 g (0.1 mole) of 1,2-cyclohexane diol was dissolved in 13.8 g (0.1 mole) of diethyl phosphite in a round bottom flask with a Claisen head having a downward condenser and a receiver for distillation. 0.05 g of sodium was then dissolved in a small amount of ethanol and the alcoholic sodium ethoxide so formed was added to the mixture.
The mixture was next heated to 1 700C under a stream of dry nitrogen and the transesterified ethanol was collected (70% of expected amount).
The remaining product was then incorporated in a high vacuum line and maintained at 1 70CC for 2 days when a yellow solid was obtained. This was the corresponding polyphosphite of the formula:
The polyphosphite was then oxidised by dissolution in a solution of N204 in dimethyl formamide (formed by bubbing NO2 into dimethyl formamide until a green-brown solution was obtained), excess N204 being removed by passing nitrogen through the solution. Finally, the dimethyl formamide was removed by vacuum distillation and the remaining polymer cleaned by dissolution in methanol and precipitation by diethyl ether.
Example 2
In this Example three solutions were utilised: (A) a commercial APF solution ("ALPHAGEL"
ex AD International Ltd.), as received
comprising 15,000 ppm F- (comparative);
(B) an aqueous solution comprising 0.5 wt%
poly(cyclohexylene phosphate) and 10 ppm
F-, as sodium fluoride; and
(C) an aqueous solution comprising 0.5 wt%
poly(cyclohexylene phosphate) and 1 wt%
sodium fluoride (about 4,500 ppm F-).
Three sets of 5 molar teeth (all 8s) were painted with nail varnish (10% poiystyrene in ethylacetate) so that each tooth in each set retained an unvarnished area 3 mmx4 mm of exposed enamel. All of the painted teeth in a given set were then immersed in one of the three solutions supra for 24 hours at 250C. The resulting fluoridated teeth were removed; washed with distilled water; dried; and weighed. Each fluoridated tooth was next immersed in a separate 1 ml aliquot of 2N perchloric acid for 10 minutes at 250C. The resulting etched tooth was removed; washed with distilled water; dried; and weighed.
The aliquot of perchloric acid and the washings were analysed for fluoride content by the method of Weatherall and Hargreaves (Arch. Orai Biol. 10, pages 139-142, 1965). The etching and weighing procedure was repeated 10 times for each tooth thereby enabling the estimation of the fluoride content of the enamel at several depths.
Finally, the nail varnish was removed and the etching and weighing procedure repeated for the unfluoridated enamel.
Figure 1 of the accompanying drawings illustrates graphically the observed variation of fluoride concentration, as ordinate, (ppm F-) against enamel depth, as abscissa, (as g.cm-2x 10-2).
From the Figure, it can be seen that the two solutions (A and C) containing high fluoride concentrations also create high fluoride concentrations in the enamel surface, but that this fluoride concentration decreases with enamel depth. The decrease with enamel depth is greater in the case of immersion in solution A than in the case of immersion in solution C. At enamel depths greater than 25 g.cm-2x10-2 the fluoride concentration is greater than in tne case of immersion in solution C than in the case of immersion in solution A. The solution B containing low fluoride concentration, however, creates an increased concentration of fluoride with increasing enamel depth such that at enamel depths of 30 to 35 g.cm-2x 10-2 there is no significant difference in fluoride concentration between the case of immersion in solution A and solution B.
Example 3
In this Example eight solutions were utilised: (A) as in Example 2 (comparative);
(D) an aqueous solution comprising 0.1 wt%
poly(cyclohexylene phosphate) and 10
ppm F-, as sodium fluoride;
(E) an aqueous solution comprising 0.1 wt%
poly(cyclohexylene phosphate) and 50
ppm F-, as sodium fluoride;
(F) an aqueous solution comprising 0.1 wt%
poly(cyclohexylene phosphate) and 100
ppm F-, as sodium fluoride;
(G) an aqueous solution comprising 0.1 wt%
poly(cyclohexylene phosphate) and 200
ppm F, as sodium fluoride;
(H) an aqueous solution comprising 0.1 wt%
poly(cyclohexylene phosphate) and 500
ppm F-, as sodium fluoride;
(I) an aqueous solution comprising 0.1 wt%
poly(cyclohexylene phosphate) and 5,000
ppm F-, as sodium fluoride;;
(J) an aqueous solution comprising 0.1 wt%
poly(cyclohexylene phosphate) and
10,000 ppm F-, as sodium fluoride.
Eight sets of 5 teeth (all 8s) were painted with nail varnish and all of the teeth in a given set were immersed in one of eight solutions supra essentially as in Example 2 except that the time of immersion was 1 5 minutes at 250C. The resulting fluoridated teeth were removed; washed with distilled water; dried; and weighed. Each fluoridated tooth was then immersed in a separate aliquot Tyrodes solution for 24 hours at 250 C, the solution being changed hourly. Each tooth so treated was next etched and estimated for fluoride as in Example 2.
Tyrodes solution has the composition: Component g litre- CaCI2 0.200
KCI 0.200 MgCI2 6H2O 0.05
NaCI 8.00
NaHCO3 1.00
NaH2PO4 H20 0.05
Glucose 1.00
Figure 2 of the accompanying drawings illustrates graphically, on a logarithmic scale, the observed variation of retained fluoride concentration, as ordinate, (ppm F-) against fluoride concentration in the immersion solution, as abscissa, (ppm F-).
From the Figure, it can be seen that the fluoride concentration retained by teeth treated with solution A was that expected for teeth treated with an aqueous solution comprising 0.1 wt% poly(cyclohexylene phosphate) and 800 ppm F-, as sodium fluoride. It is also observed that an aqueous solution comprising 0.1 wt% poly (cyclohexylene phosphate) and 100 ppm F-, as sodium fluoride gave a fluoride concentration retained by teeth of 550 ppm: comparison with solution A shows that a 1 50 times reduction in Fcontent of the solutions of the invention gives only a 30% reduction in fluoride concentration retained by the teeth.
Example 4
Eight sets of 5 teeth (all 8s) were painted with nail varnish and all of the teeth in a given set were immersed for 15 minutes at 250C in one of the eight solutions used in Example 3. The calcium content of each solution was then determined using a Ca+2 electrode.
Figure 3 of the accompanying drawings illustrates graphically on a logarithmic scale, the observed variation in solution calcium concentration, as ordinate, (M Ca+2)/cm2x 10) against fluoride concentration in the immersion solution, as abscissa, (ppm F-).
From the Figure, it can be seen that at about 100 ppm F- there is a pronounced change of curve gradient with dissolved calcium content decreasing rapidly with increasing fluoride concentrations.
Example 5
Eight sets of 5 teeth (ali 8s) were painted with nail varnish so that each tooth in each set retained two unvarnished areas, each 4 mmx3 mm, of exposed enamel. All of the painted teeth in a given set then had one (but not the other, which acted as control) of the unvarnished areas contacted for 1 5 minutes at 250C with one of the eight solutions used in Example 3. Each unvarnished area on a given tooth was contacted for 30 minutes with separate aliquots of acetate buffer (pH=4.5). The aliquots were analysed for
Ca+2 using a Ca+2 electrode.
Figure 4 of the accompanying drawings illustrates graphically, on a logarithmic scale, the observed variation in solution calcium concentration, as ordinate, ([Ca+2] test/[Ca+2] control) against fluoride concentration in the immersion solution, as abscissa, (ppm F-).
From the Figure, it can be seen that the enamel is about 65% less soluble when treated with the solution of the invention. Solution A, despite its very high fluoride concentration, renders enamel treated therewith only 19% less soluble.
It will be seen that the compositions of this invention provide both an enhanced sub-surface uptake of fluoride and an enhanced retention of fluoride by dental enamel, for a given fluoride concentration, relative to conventional APF compositions. The compositions of this invention also provide enhanced acid resistance in treated dental enamel, relative to conventional APF compositions.
Claims (22)
1. A polymer which is permselective with respect to fluoride ion and which comprises both hydrophobic groups and backbone phosphate groups for use in dental prophylaxis or therapy.
2. A permselective polymer according to Claim
1 wherein the polymer comprises a saturated or unsaturated, substituted or unsubstituted poly (organo phosphate).
3. A permselective polymer according to Claim 1 or 2 wherein the polymer comprises a substituted or unsubstituted poly(cycloalkylene phosphate).
4. A permselective polymer according to any preceding claim wherein the polymer comprises a substituted or unsubstituted poly(cyclohexylene phosphate).
5. A permselective polymer according to any preceding claim for use in reduction of dental caries.
6. A permselective polymer according to any preceding claim for use in enhancing the resistance of dental enamel to acid attack.
7. A composition comprising:
(i) a polymer which is permselective with respect to fluoride ion and which comprises both hydrophobic groups and backbone phosphate groups; and
(ii) a source of fluoride ion.
8. A composition according to Claim 7 wherein the polymer comprises a saturated or unsaturated, substituted or unsubstituted poly(organo phosphate).
9. A composition according to any of Claims 7 or 8 wherein the polymer comprises a substituted or unsubstituted poly(cycloalkylene phosphate).
10. A composition according to any of Claims 7 to 9 wherein the polymer comprises a substituted or unsubstituted poly(cyclohexylene phosphate).
11. A composition according to any of Claims 7 to 10 wherein the source of fluoride ion comprises a fluoride complex; a fluoride of a transition metal of Groups IVA or VII; a fluoride of a metal of Group IVB; or an alkali metal fluoride.
12. A composition according to Claim 11, wherein the source of fluoride ion comprises sodium fluoride.
1 3. A composition according to Claim 11 or 12 wherein the source of fluoride ion comprises up to 25,000 ppm (as F-) of the composition.
14. A composition according to Claim 13 wherein the source of fluoride ion comprises up to 10,000 ppm (as F-) of the composition.
15. A composition according to Claim 13 wherein the source of fluoride ion comprises less than 2,500 ppm (as F-) of the composition.
16. A composition according to Claim 13 wherein the source of fluoride ion comprises less than 1,000 ppm (as F-) of the composition.
17. A composition according to any of Claims 7 to 16 which is formulated as a gel.
1 8. A composition according to any of Claims 7 to 1 7 which is a dentifrice or a toothpaste.
19. A composition according to any of Claims 7 to 1 6 which comprises a disinfectant.
20. A composition according to any of Claims 7 to 16 and 1 9 which is a mouthwash.
21. A composition according to any of Claims 7 to 20 for use in dental prophylaxis or therapy.
22. A composition according to Claim 17 for topical use in dental prophylaxis or therapy.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GB08321144A GB2126081B (en) | 1982-08-24 | 1983-08-05 | Fluoride-containing compositions containing permselective polymers |
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GB8224265 | 1982-08-24 | ||
GB08321144A GB2126081B (en) | 1982-08-24 | 1983-08-05 | Fluoride-containing compositions containing permselective polymers |
Publications (3)
Publication Number | Publication Date |
---|---|
GB8321144D0 GB8321144D0 (en) | 1983-09-07 |
GB2126081A true GB2126081A (en) | 1984-03-21 |
GB2126081B GB2126081B (en) | 1986-04-30 |
Family
ID=26283659
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
GB08321144A Expired GB2126081B (en) | 1982-08-24 | 1983-08-05 | Fluoride-containing compositions containing permselective polymers |
Country Status (1)
Country | Link |
---|---|
GB (1) | GB2126081B (en) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0228209A2 (en) * | 1985-12-11 | 1987-07-08 | Unilever Plc | Oral hygiene product |
Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1979000456A1 (en) * | 1977-12-29 | 1979-07-26 | Minnesota Mining & Mfg | Compositions and methods for inhibiting plaque formation |
GB2090265A (en) * | 1980-12-31 | 1982-07-07 | Colgate Palmolive Co | Antigingivitis activity |
-
1983
- 1983-08-05 GB GB08321144A patent/GB2126081B/en not_active Expired
Patent Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1979000456A1 (en) * | 1977-12-29 | 1979-07-26 | Minnesota Mining & Mfg | Compositions and methods for inhibiting plaque formation |
GB2090265A (en) * | 1980-12-31 | 1982-07-07 | Colgate Palmolive Co | Antigingivitis activity |
Cited By (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0228209A2 (en) * | 1985-12-11 | 1987-07-08 | Unilever Plc | Oral hygiene product |
EP0228209A3 (en) * | 1985-12-11 | 1988-09-07 | Unilever Plc | Oral hygiene product |
US4837007A (en) * | 1985-12-11 | 1989-06-06 | Lever Brothers Company | Fluoridating oral cavity |
AU590647B2 (en) * | 1985-12-11 | 1989-11-09 | Unilever Plc | Oral hygiene product |
Also Published As
Publication number | Publication date |
---|---|
GB2126081B (en) | 1986-04-30 |
GB8321144D0 (en) | 1983-09-07 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CA2996319C (en) | High water oral care composition comprising zinc and tin salts | |
US5009882A (en) | Use of a carboxy starch polymer to inhibit plaque without tooth staining | |
US4842847A (en) | Dental calculus inhibiting compositions | |
US4732617A (en) | Fluoride-containing compositions | |
US4892725A (en) | Tartar inhibition on teeth | |
US4362713A (en) | Salts of maleic acid copolymers as dental plaque barrier agents | |
JPS6347685B2 (en) | ||
US4915937A (en) | Dental antihydrolysis agent | |
GB2166350A (en) | Oral compositions | |
CA1176795A (en) | Sulfonated polyamino acids as dental plaque barriers | |
US4375461A (en) | Sulfonated vinyl aromatic homopolymers and copolymers as dental plaque barriers | |
US4364927A (en) | Sulfonated naphthalene formaldehyde condensation polymers as dental plaque barriers | |
US5068100A (en) | Anticalculus compositions | |
US4362712A (en) | Carboxylated naphthalene formaldehyde condensation polymers as dental plaque barriers | |
WO1992017194A1 (en) | Polyanionic polyamino acid inhibitors of mineral deposition and their synthesis | |
GB2126081A (en) | Fluoride-containing compositions containing permselective polymers | |
US4361547A (en) | Sulfonated aromatic formaldehyde condensation polymers as dental plaque barriers | |
US5188818A (en) | Toothpaste composition containing strontium salt of maleic anhydride-methyl vinyl ether copolymer | |
US4360513A (en) | Sulfonated poly(arylene ether sulfone) polymers as dental plaque barriers | |
BR112017009711B1 (en) | COMPOSITIONS, TOOTH PASTE, DENTAL GEL, TOOTHPASTE, DENTAL POWDER, PROPHYLATIC PASTE, RINSE, RINSE SOLUTION, DENTAL MOUSSE, DENTAL FLUIS, CHEWING GUM, STRIP OR DIFFICULT ORAL CARE FILM FOR A SUPER SOLUBLE ORAL APPLICATION , PHOSPHATE COMPOUND AND ORAL CARE METHOD | |
EP0045194B1 (en) | Oral hygiene compositions comprising sulfonated poly (arylene ether sulfone) polymers as dental plaque barriers | |
US4364924A (en) | Alkali metal salts of poly(vinylbenzoic acid) as dental plaque barrier agents | |
CA1167382A (en) | Zinc salts of sulfonated poly (arylene ether sulfone) polymers as highly substantive dental plaque barriers | |
US4020019A (en) | Anticaries agents | |
Shrestha | Effect of systemic titanium tetrafluoride (TiF4) on fluoride uptake by developing rat enamel |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PCNP | Patent ceased through non-payment of renewal fee |